Veracyte (VCYT)
Veracyte on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as services-medical laboratories.
10.2M
Short interest
settlement 2026-09-30
5.9
Days to cover
-1.9 days vs prior
61.8%
Short share of volume
2026-10-12
3,492
Fails to deliver
settlement 2026-09-11
Tue 3 Nov
Next earnings
estimated date
-$1.3M
Insider flow, 90 days
0 buys, 9 sells
As of 2026-10-12.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in VCYT is 10,178,975 shares, up 2,101,747 shares over the last month. Over the last 48 readings it ranged from 2,547,939 shares (13 December 2024) to 10,178,975 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 1.7M shares a day that is 5.9 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/vcyt" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 10,178,975 | +21.1% | 1,729,842 | 5.88 |
| 2026-09-15 | 8,403,932 | +4.0% | 1,082,744 | 7.76 |
| 2026-08-31 | 8,077,228 | +19.0% | 1,382,806 | 5.84 |
| 2026-08-14 | 6,789,714 | -1.0% | 1,211,893 | 5.60 |
| 2026-07-31 | 6,858,686 | +2.8% | 1,426,852 | 4.81 |
| 2026-07-15 | 6,674,331 | -0.6% | 988,654 | 6.75 |
| 2026-06-30 | 6,717,490 | -20.9% | 1,771,986 | 3.79 |
| 2026-06-15 | 8,491,267 | +15.5% | 1,305,244 | 6.51 |
| 2026-05-29 | 7,352,514 | -14.4% | 1,136,565 | 6.47 |
| 2026-05-15 | 8,590,160 | +25.0% | 1,190,565 | 7.22 |
| 2026-04-30 | 6,870,870 | +6.5% | 744,725 | 9.23 |
| 2026-04-15 | 6,450,935 | +2.0% | 630,681 | 10.23 |
| 2026-03-31 | 6,325,353 | +17.6% | 1,137,516 | 5.56 |
| 2026-03-13 | 5,378,206 | -2.1% | 972,059 | 5.53 |
| 2026-02-27 | 5,491,867 | -9.3% | 829,358 | 6.62 |
| 2026-02-13 | 6,051,605 | +7.4% | 927,251 | 6.53 |
| 2026-01-30 | 5,633,223 | +8.8% | 816,662 | 6.90 |
| 2026-01-15 | 5,177,380 | +3.8% | 738,967 | 7.01 |
| 2025-12-31 | 4,990,310 | -5.0% | 615,691 | 8.11 |
| 2025-12-15 | 5,255,522 | -7.9% | 904,960 | 5.81 |
| 2025-11-28 | 5,707,781 | +4.7% | 1,087,253 | 5.25 |
| 2025-11-14 | 5,450,021 | -9.8% | 1,334,467 | 4.08 |
| 2025-10-31 | 6,044,127 | -10.1% | 686,286 | 8.81 |
| 2025-10-15 | 6,722,370 | -8.3% | 813,065 | 8.27 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 12 October 2026, the short share of VCYT volume is 61.8%, down 25.1 points over the last five sessions. Over the last 30 readings it ranged from 35.7% (9 September 2026) to 86.9% (5 October 2026). The latest reading is 8.0 points below the 30-session average of 69.8%, on 387K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-12 | 239K | 387K | 61.8% | 0 |
| 2026-10-09 | 252K | 334K | 75.5% | 355 |
| 2026-10-08 | 246K | 345K | 71.3% | 1 |
| 2026-10-07 | 382K | 475K | 80.4% | 1,366 |
| 2026-10-06 | 580K | 761K | 76.2% | 140 |
| 2026-10-05 | 425K | 489K | 86.9% | 0 |
| 2026-10-02 | 337K | 419K | 80.5% | 0 |
| 2026-10-01 | 443K | 538K | 82.3% | 0 |
| 2026-09-30 | 313K | 411K | 76.3% | 80 |
| 2026-09-29 | 338K | 561K | 60.2% | 880 |
| 2026-09-28 | 444K | 743K | 59.8% | 3,325 |
| 2026-09-25 | 504K | 738K | 68.3% | 40 |
| 2026-09-24 | 991K | 1.3M | 76.1% | 5,010 |
| 2026-09-23 | 309K | 763K | 40.5% | 80 |
| 2026-09-22 | 348K | 541K | 64.4% | 0 |
| 2026-09-21 | 441K | 631K | 69.9% | 0 |
| 2026-09-18 | 245K | 341K | 71.9% | 634 |
| 2026-09-17 | 403K | 525K | 76.7% | 0 |
| 2026-09-16 | 489K | 574K | 85.1% | 6 |
| 2026-09-15 | 407K | 614K | 66.2% | 0 |
| 2026-09-14 | 291K | 409K | 71.2% | 1 |
| 2026-09-11 | 243K | 360K | 67.6% | 5,110 |
| 2026-09-10 | 208K | 307K | 67.8% | 0 |
| 2026-09-09 | 278K | 778K | 35.7% | 40 |
| 2026-09-08 | 358K | 418K | 85.7% | 180 |
| 2026-09-04 | 281K | 404K | 69.6% | 0 |
| 2026-09-03 | 221K | 297K | 74.3% | 0 |
| 2026-09-02 | 390K | 512K | 76.3% | 0 |
| 2026-09-01 | 222K | 418K | 53.1% | 156 |
| 2026-08-31 | 328K | 512K | 64.0% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 11 September 2026, the fails-to-deliver balance in VCYT is 3,492 shares, down 995 shares over the last settlement date. Over the last 30 readings it ranged from 10 shares (19 March 2026) to 181,829 shares (30 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-11 | 3,492 | $42.03 | $147K |
| 2026-09-03 | 4,487 | $44.88 | $201K |
| 2026-08-28 | 11,043 | $45.25 | $500K |
| 2026-08-27 | 5,028 | $44.29 | $223K |
| 2026-08-17 | 1,018 | $41.25 | $42K |
| 2026-08-05 | 24,423 | $46.41 | $1.1M |
| 2026-08-04 | 29,403 | $44.85 | $1.3M |
| 2026-08-03 | 70,656 | $46.32 | $3.3M |
| 2026-07-31 | 1,211 | $59.78 | $72K |
| 2026-07-07 | 56 | $58.00 | $3K |
| 2026-07-01 | 483 | $58.73 | $28K |
| 2026-06-30 | 181,829 | $60.19 | $10.9M |
| 2026-06-29 | 30 | $60.49 | $2K |
| 2026-06-15 | 2,435 | $47.33 | $115K |
| 2026-05-28 | 6,355 | $44.49 | $283K |
| 2026-05-26 | 9,257 | $45.03 | $417K |
| 2026-05-19 | 204 | $41.50 | $8K |
| 2026-05-15 | 59,772 | $38.90 | $2.3M |
| 2026-05-14 | 13 | $38.25 | $497 |
| 2026-05-08 | 116,620 | $40.76 | $4.8M |
| 2026-05-01 | 5,139 | $32.92 | $169K |
| 2026-04-30 | 18 | $31.78 | $572 |
| 2026-04-22 | 556 | $33.51 | $19K |
| 2026-04-21 | 3,005 | $33.45 | $101K |
| 2026-04-17 | 307 | $33.03 | $10K |
| 2026-04-10 | 1,440 | $31.35 | $45K |
| 2026-03-26 | 9,527 | $32.79 | $312K |
| 2026-03-23 | 2,159 | $31.84 | $69K |
| 2026-03-20 | 237 | $32.78 | $8K |
| 2026-03-19 | 10 | $33.28 | $333 |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at VCYT reported 9 open-market sells worth $1.3M in the last 90 days and no open-market buys. Latest filing: Leite John (Global Chief Commercial Off) on 2026-09-21.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-21 | Leite John | Global Chief Commercial Off | Sell | 4K | $40.00 | $161K | 124K |
| 2026-09-14 | Holstein Jens | Director | Sell | 5K | $40.95 | $205K | 27K |
| 2026-09-04 | McGuire Annie | EVP, General Counsel | Sell | 1K | $43.67 | $48K | 131K |
| 2026-09-04 | McGuire Annie | EVP, General Counsel | Sell | 2K | $42.79 | $92K | 132K |
| 2026-09-04 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 3K | $43.66 | $118K | 133K |
| 2026-09-04 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 10K | $42.89 | $446K | 136K |
| 2026-09-04 | Chambers Rebecca | Chief Financial Officer | Sell | 1K | $43.71 | $51K | 166K |
| 2026-09-04 | Chambers Rebecca | Chief Financial Officer | Sell | 2K | $42.81 | $106K | 167K |
| 2026-09-02 | Wygant Jonathan | VP, Chief Accounting Officer | Tax withholding | 1K | $44.88 | $61K | 43K |
| 2026-09-02 | Stapley Marc | Chief Executive Officer | Tax withholding | 9K | $44.88 | $394K | 432K |
| 2026-09-02 | McGuire Annie | EVP, General Counsel | Tax withholding | 3K | $44.88 | $144K | 134K |
| 2026-09-02 | Leite John | Global Chief Commercial Off | Tax withholding | 4K | $44.88 | $178K | 128K |
| 2026-09-02 | Febbo Phillip G. | Chief Scientific & Med Officer | Tax withholding | 4K | $44.88 | $163K | 146K |
| 2026-09-02 | Chambers Rebecca | Chief Financial Officer | Tax withholding | 4K | $44.88 | $162K | 170K |
| 2026-09-01 | Bhanji Muna | Director | Sell | 2K | $42.97 | $80K | 43K |
| 2026-06-18 | EASTHAM KARIN | Director | Sell | 529 | $53.55 | $28K | 15K |
| 2026-06-18 | EASTHAM KARIN | Director | Sell | 3K | $52.78 | $169K | 16K |
| 2026-06-11 | Miller Thomas F. | Director | Grant | 5K | $0.00 | $0 | 31K |
| 2026-06-11 | Bhanji Muna | Director | Grant | 5K | $0.00 | $0 | 45K |
| 2026-06-11 | Holstein Jens | Director | Grant | 5K | $0.00 | $0 | 32K |
| 2026-06-11 | EPSTEIN ROBERT S | Director | Grant | 5K | $0.00 | $0 | 58K |
| 2026-06-11 | Shafer David Brent | Director | Grant | 5K | $0.00 | $0 | 31K |
| 2026-06-11 | JONES EVAN/ FA | Director | Grant | 5K | $0.00 | $0 | 35K |
| 2026-06-11 | EASTHAM KARIN | Director | Grant | 5K | $0.00 | $0 | 19K |
| 2026-06-11 | Barr Eliav | Director | Grant | 5K | $0.00 | $0 | 56K |
| 2026-06-04 | Stapley Marc | Chief Executive Officer | Sell | 138K | $50.12 | $6.9M | 440K |
| 2026-06-04 | Stapley Marc | Chief Executive Officer | Option exercise | 138K | $36.60 | $5.1M | 579K |
| 2026-06-04 | McGuire Annie | EVP, General Counsel | Sell | 2K | $50.12 | $89K | 137K |
| 2026-06-04 | McGuire Annie | EVP, General Counsel | Sell | 1K | $49.31 | $69K | 139K |
| 2026-06-04 | Leite John | Global Chief Commercial Off | Sell | 14K | $50.07 | $700K | 132K |
| 2026-06-04 | Chambers Rebecca | Chief Financial Officer | Sell | 2K | $50.09 | $98K | 173K |
| 2026-06-04 | Chambers Rebecca | Chief Financial Officer | Sell | 2K | $49.28 | $79K | 175K |
| 2026-06-02 | Wygant Jonathan | VP, Chief Accounting Officer | Tax withholding | 1K | $47.80 | $65K | 44K |
| 2026-06-02 | Stapley Marc | Chief Executive Officer | Tax withholding | 9K | $47.80 | $431K | 440K |
| 2026-06-02 | McGuire Annie | EVP, General Counsel | Tax withholding | 3K | $47.80 | $157K | 140K |
| 2026-06-02 | Leite John | Global Chief Commercial Off | Tax withholding | 4K | $47.80 | $194K | 146K |
| 2026-06-02 | Febbo Phillip G. | Chief Scientific & Med Officer | Tax withholding | 4K | $47.80 | $178K | 150K |
| 2026-06-02 | Chambers Rebecca | Chief Financial Officer | Tax withholding | 4K | $47.80 | $177K | 177K |
| 2026-05-22 | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 24K | $45.40 | $1.1M | 45K |
| 2026-05-22 | Wygant Jonathan | VP, Chief Accounting Officer | Option exercise | 24K | $24.80 | $595K | 69K |
| 2026-05-20 | EPSTEIN ROBERT S | Director | Sell | 10K | $44.01 | $440K | 52K |
| 2026-05-06 | McGuire Annie | SVP, General Counsel | Sell | 5K | $40.00 | $204K | 144K |
| 2026-05-06 | McGuire Annie | SVP, General Counsel | Sell | 5K | $38.05 | $194K | 149K |
| 2026-04-10 | Haas Kevin Richard | Chief Dev and Tech Officer | Grant | 44K | $0.00 | $0 | 44K |
| 2026-03-06 | Wygant Jonathan | VP, Chief Accounting Officer | Grant | 11K | $0.00 | $0 | 45K |
| 2026-03-06 | Stapley Marc | Chief Executive Officer | Grant | 92K | $0.00 | $0 | 450K |
| 2026-03-06 | McGuire Annie | SVP, General Counsel | Grant | 26K | $0.00 | $0 | 154K |
| 2026-03-06 | McGuire Annie | SVP, General Counsel | Grant | 33K | $0.00 | $0 | 128K |
| 2026-03-06 | Leite John | Chief Commercial Officer-CLIA | Grant | 7K | $0.00 | $0 | 150K |
| 2026-03-06 | Leite John | Chief Commercial Officer-CLIA | Grant | 36K | $0.00 | $0 | 144K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON34 Form 144 notices on file for VCYT worth $18.8M at the prices reported; 7 in the last 90 days worth $1.8M. Latest: JENS HOLSTEIN filed on 2026-09-24 to sell 7,500 shares ($353K) from 2026-09-24.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-24 | JENS HOLSTEINDirector | 8K | $353K | 0.009% | 2026-09-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-21 | JOHN LEITEOfficer | 4K | $160K | 0.005% | 2026-09-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-14 | JENS HOLSTEINDirector | 5K | $205K | 0.006% | 2026-09-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-04 | ANN MCGUIREOfficer | 3K | $145K | 0.004% | 2026-09-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-04 | PHILLIP FEBBOOfficer | 13K | $586K | 0.016% | 2026-09-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-04 | REBECCA CHAMBERSOfficer | 4K | $163K | 0.005% | 2026-09-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-01 | MUNA BHANJIDirector | 4K | $161K | 0.005% | 2026-09-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-18 | KARIN EASTHAMDirector | 4K | $191K | 0.005% | 2026-06-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-04 | MARC STAPLEYDirector, Officer | 138K | $6.7M | 0.173% | 2026-06-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-04 | ANN MCGUIREOfficer | 3K | $155K | 0.004% | 2026-06-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-04 | John LeiteOfficer | 14K | $680K | 0.018% | 2026-06-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-04 | REBECCA CHAMBERSOfficer | 4K | $173K | 0.004% | 2026-06-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-20 | ROBERT EPSTEINDirector | 10K | $417K | 0.013% | 2026-05-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-06 | ANN MCGUIREOfficer | 10K | $336K | 0.013% | 2026-05-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-04 | MARC STAPLEYDirector, Officer | 46K | $1.6M | 0.057% | 2026-03-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-04 | ANN MCGUIREOfficer | 7K | $234K | 0.008% | 2026-03-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-04 | John LeiteOfficer | 5K | $185K | 0.007% | 2026-03-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-04 | REBECCA CHAMBERSOfficer | 18K | $643K | 0.023% | 2026-03-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-02 | PHILLIP FEBBOOfficer | 13K | $491K | 0.017% | 2026-03-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-16 | ANN MCGUIREOfficer | 11K | $467K | 0.014% | 2025-12-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-05 | KARIN EASTHAMDirector | 20K | $948K | 0.025% | 2025-12-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-04 | MARC STAPLEYDirector, Officer | 8K | $366K | 0.010% | 2025-12-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-04 | ANN MCGUIREOfficer | 1K | $68K | 0.002% | 2025-12-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-04 | REBECCA CHAMBERSOfficer | 13K | $634K | 0.017% | 2025-12-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-25 | John LeiteOfficer | 4K | $191K | 0.005% | 2025-11-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-20 | JENS HOLSTEINDirector | 10K | $424K | 0.013% | 2025-11-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-05 | ANN MCGUIREOfficer | 6K | $234K | 0.008% | 2025-11-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-05 | KARIN EASTHAMDirector | 10K | $349K | 0.012% | 2025-11-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-05 | REBECCA CHAMBERSOfficer | 7K | $253K | 0.009% | 2025-11-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-06 | PHILLIP FEBBOOfficer | 8K | $301K | 0.011% | 2025-10-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-01 | ANN MCGUIREOfficer | 2K | $74K | 0.003% | 2025-10-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-01 | John LeiteOfficer | 3K | $87K | 0.003% | 2025-10-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-01 | ROBERT S EPSTEINDirector | 21K | $737K | 0.027% | 2025-10-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-19 | ANN MCGUIREOfficer | 2K | $76K | 0.003% | 2025-09-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON9 holders report 5% or more of VCYT in their latest filing, all on Schedule 13G (passive). The largest reported stake is Abigail P. Johnson at 10.1% of the class (8,059,903 shares), filed 2026-06-05 for an event on 2026-05-29.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-06-05 | 13G/Ano. 5 | Abigail P. Johnsonindividual | 8.1M | 10.1% | 2026-05-29 |
| 2026-06-05 | 13G/Ano. 5 | FMR LLCparent holding company | 8.1M | 10.1% | 2026-05-29 |
| 2026-05-13 | 13G/Ano. 6 | Artisan Partners Limited Partnershipinvestment adviser | 5.5M | 6.9% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 6 | Artisan Investments GP LLCparent holding company | 5.5M | 6.9% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 6 | Artisan Partners Holdings LPparent holding company | 5.5M | 6.9% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 6 | Artisan Partners Asset Management Inc.parent holding company | 5.5M | 6.9% | 2026-03-31 |
| 2026-05-12 | 13G | STATE STREET CORPORATIONparent holding company | 5.0M | 6.3% | 2026-03-31 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 4.1M | 5.2% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 4.5M | 5.7% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 6 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-01-08 | 13G/Ano. 1 | ARK Investment Management LLCinvestment adviser | 3.9M | 4.9% | 2025-12-31 |
| 2026-01-08 | 13G/Ano. 1 | Catherine D. Woodparent holding company, individual | 3.9M | 4.9% | 2025-12-31 |
13F holders
Tracked managers holding VCYT at their latest 13F. JSON7 of the 30 tracked managers held VCYT at their latest 13F, $260.0M in total at quarter-end prices. ARK Investment Management is the largest at $134.8M (0.9% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| ARK Investment Management | 2026-06-30 | 2.3M | $134.8M | 0.88% | -758K |
| Point72 Asset Management | 2026-06-30 | 738K | $43.3M | 0.05% | +254K |
| Fisher Asset Management | 2026-06-30 | 701K | $41.1M | 0.01% | -36K |
| D. E. Shaw & Co. | 2026-06-30 | 413K | $24.3M | 0.01% | +371K |
| AQR Capital Management | 2026-06-30 | 150K | $8.8M | 0.00% | +59K |
| Millennium Management | 2026-06-30 | 72K | $4.2M | 0.00% | new |
| Bridgewater Associates | 2026-06-30 | 58K | $3.4M | 0.01% | -33K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Veracyte reported revenue of $150.3M, up 15.5% from the same quarter a year earlier, and net income of $25.5M (0.31 diluted EPS). In FY 2025 it generated $136.3M of operating cash flow.
- Cash
- $299.5M
- Equity
- $1.39B
- Total assets
- $1.49B
- Shares outstanding
- 80,390,731
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $150.3M | $25.5M | 17.0% | 0.31 |
| Q1 FY 2026 | 2026-03-31 | $139.1M | $28.7M | 20.6% | 0.35 |
| Q4 FY 2025derived | 2025-12-31 | $140.6M | $41.1M | 29.3% | n/a |
| Q3 FY 2025 | 2025-09-30 | $131.9M | $19.1M | 14.5% | 0.24 |
| Q2 FY 2025 | 2025-06-30 | $130.2M | -$980K | -0.8% | -0.01 |
| Q1 FY 2025 | 2025-03-31 | $114.5M | $7.0M | 6.2% | 0.09 |
| Q4 FY 2024derived | 2024-12-31 | $118.6M | $5.1M | 4.3% | n/a |
| Q3 FY 2024 | 2024-09-30 | $115.9M | $15.2M | 13.1% | 0.19 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $517.1M | $66.4M | $136.3M | $9.7M | n/a | n/a |
| FY 2024 | 2024-12-31 | $445.8M | $24.1M | $75.1M | $11.3M | n/a | n/a |
| FY 2023 | 2023-12-31 | $361.1M | -$74.4M | $44.2M | $10.0M | n/a | n/a |
| FY 2022 | 2022-12-31 | $296.5M | -$36.6M | $7.5M | $8.5M | n/a | n/a |
| FY 2021 | 2021-12-31 | $219.5M | -$75.6M | -$31.6M | $5.4M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-27 from the cover page.
What this page is
Veracyte in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Veracyte (VCYT), SEC CIK 1384101, listed on Nasdaq, classified by the SEC as services-medical laboratories. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-12.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-11.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-24.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-06-05.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-21.JSON and CSV
- Company record
- EDGAR filing index for CIK 1384101Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-medical laboratories
Other company pages
Datasets
Frequently Asked Questions
How much of VCYT is sold short?
What is VCYT's daily short volume?
Does VCYT have fails to deliver?
Are VCYT insiders buying or selling?
Have VCYT insiders filed to sell?
Who owns 5% or more of VCYT?
What did VCYT report last quarter?
Which tracked 13F managers own VCYT?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.